Circular RNA circEsyt2 regulates vascular smooth muscle cell remodeling via splicing regulation.

Journal Article (Journal Article)

Circular RNAs (circRNAs) have been recently recognized as playing a role in the pathogenesis of vascular remodeling-related diseases by modulating the functions of miRNAs. However, the interplay between circRNAs and proteins during vascular remodeling remains poorly understood. Here, we investigated a previously identified circRNA, circEsyt2, whose expression is known to be upregulated during vascular remodeling. Loss- and gain-of‑function mutation analyses in vascular smooth muscle cells (VSMCs) revealed that circEsyt2 enhanced cell proliferation and migration and inhibited apoptosis and differentiation. Furthermore, the silencing of circEsyt2 in vivo reduced neointima formation, while circEsyt2 overexpression enhanced neointimal hyperplasia in the injured carotid artery, confirming its role in vascular remodeling. Using unbiased protein-RNA screening and molecular validation, circEsyt2 was found to directly interact with polyC-binding protein 1 (PCBP1), an RNA splicing factor, and regulate PCBP1 intracellular localization. Additionally, circEsyt2 silencing substantially enhanced p53β splicing via the PCBP1-U2AF65 interaction, leading to the altered expression of p53 target genes (cyclin D1, p21, PUMA, and NOXA) and the decreased proliferation of VSMCs. Thus, we identified a potentially novel circRNA that regulated vascular remodeling, via altered RNA splicing, in atherosclerotic mouse models.

Full Text

Duke Authors

Cited Authors

  • Gong, X; Tian, M; Cao, N; Yang, P; Xu, Z; Zheng, S; Liao, Q; Chen, C; Zeng, C; Jose, PA; Wang, D-Z; Jian, Z; Xiao, Y; Jiang, D-S; Wei, X; Zhang, B; Wang, Y; Chen, K; Wu, G; Zeng, C

Published Date

  • December 15, 2021

Published In

Volume / Issue

  • 131 / 24

PubMed ID

  • 34907911

Pubmed Central ID

  • PMC8670847

Electronic International Standard Serial Number (EISSN)

  • 1558-8238

Digital Object Identifier (DOI)

  • 10.1172/JCI147031

Language

  • eng

Conference Location

  • United States